101
Participants
Start Date
April 30, 2012
Primary Completion Date
December 15, 2015
Study Completion Date
January 22, 2018
enzalutamide
80 mg (2 capsules) or 160 mg (4 capsules) taken orally daily.
anastrozole
1 mg/day
exemestane
The exemestane dose is 25mg daily.
fulvestrant
500 mg every 28 days
enzalutamide
160 mg (4 capsules) taken orally daily.
exemestane
The exemestane dose is 50 mg daily.
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center - IDS Pharmacy, New York
Memorial Sloan Kettering Cancer Center - OPD Pharmacy, New York
Memorial Sloan Kettering Cancer Center, New York
Florida Cancer Specialists, Sarasota
Tennessee Oncology, PLLC., Nashville
The Sarah Cannon Research Institute, Nashville
The West Clinic, Memphis
The West Clinic, Memphis
The West Clinic, Germantown
The West Clinic, Southaven
The West Clinic, PC, Corinth
Karmanos Cancer Institute, Detroit
ATTN-Research Pharmacist, Aurora
University of Colorado Cancer Center, Aurora
University of Colorado Hospital, Anschutz Outpatient Pavilion, Aurora
Connecticut Multispecialty Group, Enfield
Lead Sponsor
Collaborators (1)
Astellas Pharma Inc
INDUSTRY
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.
INDUSTRY
Pfizer
INDUSTRY